These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 25100324)
1. Integration of binding peptide selection and multifunctional particles as tool-box for capture of soluble proteins in serum. Cusano AM; Causa F; Moglie RD; Falco N; Scognamiglio PL; Aliberti A; Vecchione R; Battista E; Marasco D; Savarese M; Raucci U; Rega N; Netti PA J R Soc Interface; 2014 Oct; 11(99):. PubMed ID: 25100324 [TBL] [Abstract][Full Text] [Related]
2. Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum. Chikkaveeraiah BV; Mani V; Patel V; Gutkind JS; Rusling JF Biosens Bioelectron; 2011 Jul; 26(11):4477-83. PubMed ID: 21632234 [TBL] [Abstract][Full Text] [Related]
3. Modification of phage display technique for improved screening of high-affinity binding peptides. Yun S; Lee S; Park JP; Choo J; Lee EK J Biotechnol; 2019 Jan; 289():88-92. PubMed ID: 30496775 [TBL] [Abstract][Full Text] [Related]
4. Identification of Soft Matter Binding Peptide Ligands Using Phage Display. Günay KA; Klok HA Bioconjug Chem; 2015 Oct; 26(10):2002-15. PubMed ID: 26275106 [TBL] [Abstract][Full Text] [Related]
5. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2). Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047 [TBL] [Abstract][Full Text] [Related]
6. Phage display selection of tight specific binding variants from a hyperthermostable Sso7d scaffold protein library. Zhao N; Schmitt MA; Fisk JD FEBS J; 2016 Apr; 283(7):1351-67. PubMed ID: 26835881 [TBL] [Abstract][Full Text] [Related]
7. Microfluidic Immunoassay System for Rapid Detection and Semi-Quantitative Determination of a Potential Serum Biomarker Mesothelin. Duan X; Zhao L; Dong H; Zhao W; Liu S; Sui G ACS Sens; 2019 Nov; 4(11):2952-2957. PubMed ID: 31602975 [TBL] [Abstract][Full Text] [Related]
8. Phage Display and Selections on Purified Antigens. Colazet M; Chames P Methods Mol Biol; 2018; 1827():165-178. PubMed ID: 30196497 [TBL] [Abstract][Full Text] [Related]
9. Using phage and yeast display to select hundreds of monoclonal antibodies: application to antigen 85, a tuberculosis biomarker. Ferrara F; Naranjo LA; Kumar S; Gaiotto T; Mukundan H; Swanson B; Bradbury AR PLoS One; 2012; 7(11):e49535. PubMed ID: 23166701 [TBL] [Abstract][Full Text] [Related]
11. High affinity peptides for the recognition of the heart disease biomarker troponin I identified using phage display. Park JP; Cropek DM; Banta S Biotechnol Bioeng; 2010 Mar; 105(4):678-86. PubMed ID: 19891006 [TBL] [Abstract][Full Text] [Related]
12. Construction of helper plasmid-mediated dual-display phage for autoantibody screening in serum. Rajaram K; Vermeeren V; Somers K; Somers V; Michiels L Appl Microbiol Biotechnol; 2014; 98(14):6365-73. PubMed ID: 24764015 [TBL] [Abstract][Full Text] [Related]
13. Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies. Nobrega FL; Ferreira D; Martins IM; Suarez-Diez M; Azeredo J; Kluskens LD; Rodrigues LR BMC Cancer; 2016 Nov; 16(1):881. PubMed ID: 27842517 [TBL] [Abstract][Full Text] [Related]
14. Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies. Sánchez-Martín D; Martínez-Torrecuadrada J; Teesalu T; Sugahara KN; Alvarez-Cienfuegos A; Ximénez-Embún P; Fernández-Periáñez R; Martín MT; Molina-Privado I; Ruppen-Cañás I; Blanco-Toribio A; Cañamero M; Cuesta AM; Compte M; Kremer L; Bellas C; Alonso-Camino V; Guijarro-Muñoz I; Sanz L; Ruoslahti E; Alvarez-Vallina L Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13791-6. PubMed ID: 23918357 [TBL] [Abstract][Full Text] [Related]
15. Advance in phage display technology for bioanalysis. Tan Y; Tian T; Liu W; Zhu Z; J Yang C Biotechnol J; 2016 Jun; 11(6):732-45. PubMed ID: 27061133 [TBL] [Abstract][Full Text] [Related]
16. Identification of novel peptides against TNF-α using phage display technique and in silico modeling of their modes of binding. Alizadeh AA; Hamzeh-Mivehroud M; Farajzadeh M; Dastmalchi S Eur J Pharm Sci; 2017 Jan; 96():490-498. PubMed ID: 27720899 [TBL] [Abstract][Full Text] [Related]
17. Screening serum biomarkers for early primary hepatocellular carcinoma using a phage display technique. Zhang Z; Xu L; Wang Z J Clin Lab Anal; 2011 Nov; 25(6):402-8. PubMed ID: 22086793 [TBL] [Abstract][Full Text] [Related]
18. Biopanning and characterization of peptides with Fe3O4 nanoparticles-binding capability via phage display random peptide library technique. You F; Yin G; Pu X; Li Y; Hu Y; Huang Z; Liao X; Yao Y; Chen X Colloids Surf B Biointerfaces; 2016 May; 141():537-545. PubMed ID: 26896661 [TBL] [Abstract][Full Text] [Related]
19. Profiling of cytokines, chemokines and other soluble proteins as a potential biomarker in colorectal cancer and polyps. Johdi NA; Mazlan L; Sagap I; Jamal R Cytokine; 2017 Nov; 99():35-42. PubMed ID: 28689023 [TBL] [Abstract][Full Text] [Related]
20. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. Zeng X; Hood BL; Sun M; Conrads TP; Day RS; Weissfeld JL; Siegfried JM; Bigbee WL J Proteome Res; 2010 Dec; 9(12):6440-9. PubMed ID: 20931982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]